Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04366531 · ClinicalTrials.gov registry record · NA

Successful Transitions and Reintegration Tools for Veterans (START-VETS)

A NA study of Substance Use Disorder and Mental Illness, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04366531 is a NA study of Substance Use Disorder and Mental Illness that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 20 participants, below the 821-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04366531, a NA study of Substance Use Disorder and Mental Illness, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study will develop prison reentry materials for Veterans leaving prison.

Interventions

  • OTHER Treatment as usual
  • BEHAVIORAL START-VET

Study Locations (1)

Texas

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-08-03
Est. Completion 2026-12-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT04366531

The ClinicalTrials.gov registry entry for NCT04366531 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 821-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (98% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Substance Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.

NCT04366531 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04366531 about?

NCT04366531 is a clinical study titled "Successful Transitions and Reintegration Tools for Veterans (START-VETS)". This study will develop prison reentry materials for Veterans leaving prison.

What is the current status of trial NCT04366531?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2020-08-03. Estimated completion is 2026-12-31.

What conditions does trial NCT04366531 study?

This clinical trial studies the following conditions: Substance Use Disorder, Mental Illness, Recently Incarcerated.

What interventions are being tested in trial NCT04366531?

The interventions under investigation include: Treatment as usual (OTHER), START-VET (BEHAVIORAL).

Who is sponsoring clinical trial NCT04366531?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04366531 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.